Article Information
Capillary Technologies IPO Day 3: Check GMP, subscription status, review, key dates. Apply or not?
Capillary Technologies' IPO opened for subscription on November 14 and will close on November 18, offering 60 lakh new shares and an OFS of 92.3 lakh shares. The price band is set between ₹549 and ₹577. Listing is scheduled for November 21.
markets 2025-11-18 03:18
View OriginalStock Symbol
Entero Healthcare Solutions Li
Sentiment
N/A
Confidence Score
N/A
Full Analysis (JSON)
{
"analysis": {
"input_data": {
"article": "Title: Capillary Technologies IPO Day 3: Check GMP, subscription status, review, key dates. Apply or not?\n\nPublished: 2025-11-18\n\nContent: Capillary Technologies\u0027 IPO opened for subscription on November 14 and will close on November 18, offering 60 lakh new shares and an OFS of 92.3 lakh shares. The price band is set between \u20b9549 and \u20b9577. Listing is scheduled for November 21.",
"full_prompt_sent_to_llm": "=== NEWS ARTICLE ===\nTitle: Capillary Technologies IPO Day 3: Check GMP, subscription status, review, key dates. Apply or not?\n\nPublished: 2025-11-18\n\nContent: Capillary Technologies\u0027 IPO opened for subscription on November 14 and will close on November 18, offering 60 lakh new shares and an OFS of 92.3 lakh shares. The price band is set between \u20b9549 and \u20b9577. Listing is scheduled for November 21.\n\n=== TOP MATCHING STOCK FROM RAG ===\n\nSymbol: ENTERO.NS\nCompany: Entero Healthcare Solutions Limited\nSector: Healthcare\nIndustry: Medical Distribution\nSimilarity Score: 0.3471 (34.71%)\n\nMarket Data:\n\u2022 Current Price: 1108.30\n\u2022 Previous Close: 1123.3\n\u2022 Day Low: 1098.0\n\u2022 Day High: 1128.5\n\u2022 52-Week Low: 1044.9\n\u2022 52-Week High: 1584.25\n\u2022 Volume: 71130\n\u2022 Avg Volume: 103787\n\nAdvanced Technical Indicators (21 total):\nClose_3d:1105.50,1123.30,1108.30 | RSI:46.46 | MACD:-11.330/-15.706/4.375 | BB:1139.91/1104.10/1068.30 | MA:1104.10/1154.11 | ATR:34.15 | OBV:-1,632,539 | WillR:-39.10 | CMF:0.1207 | Ichi:1110.25/1112.40/1111.33/1176.35 | PSAR:1089.02 | Aroon:12.00/56.00 | VWAP:1201.54 | Force:149810.87 | Mass:23.82 | Coppock:0.97 | UltOsc:51.66\n\nQuantitative Risk \u0026 Performance Metrics (35 total):\nAvgVol:79,586 | Price:1108.30 | VaR:-0.0336/-0.0616 | CVaR:-0.0487/-0.0763 | Std:0.0242 | AnnVol:0.3847 | DownDev:0.0228 | Skew:0.7749 | Kurt:5.3823 | Sharpe:-0.4654 | MaxDD:-0.3103 | VolRat:2.5646 | P/MA20:1.0038 | P/MA50:0.9603 | VolReg:0.8620 | Mom:-0.0130/-0.0751 | MeanRet:-0.0007 | W/L:0.91 | Amihud:0.000000 | Roll:0.000000 | VolSurp:-0.4780 | Omega:0.9305 | Sortino:-0.4523 | TailR:1.1116 | ESRat:1.4492 | Hurst:0.1997 | HalfL:20.24 | Mom120:-0.1417 | ApEn:0.7731\n\n=== ANALYZE THE ARTICLE (use RAG context if relevant) ===",
"rag_context": {
"company": "Entero Healthcare Solutions Limited",
"country": "India",
"description_preview": "[STOCK SYMBOL]: ENTERO.NS\n[COMPANY NAME]: Entero Healthcare Solutions Limited\n[SECTOR]: Healthcare\n[INDUSTRY]: Medical Distribution\n[COUNTRY]: India\n---------------------------------------------------...",
"full_description": "[STOCK SYMBOL]: ENTERO.NS\n[COMPANY NAME]: Entero Healthcare Solutions Limited\n[SECTOR]: Healthcare\n[INDUSTRY]: Medical Distribution\n[COUNTRY]: India\n--------------------------------------------------------------------------------\ncountry - India\nindustry - Medical Distribution\nsector - Healthcare\nlongBusinessSummary - Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.\nfullTimeEmployees - 4111\npreviousClose - 1123.3\nopen - 1125.0\ndayLow - 1098.0\ndayHigh - 1128.5\nregularMarketDayLow - 1098.0\nregularMarketDayHigh - 1128.5\npayoutRatio - 0.0\ntrailingPE - 47.201878\nvolume - 71130\nregularMarketVolume - 71130\naverageVolume - 103787\naverageVolume10days - 84302\naverageDailyVolume10Day - 84302\nmarketCap - 48220925952\nfiftyTwoWeekLow - 1044.9\nfiftyTwoWeekHigh - 1584.25\npriceToSalesTrailing12Months - 0.8925565\nfiftyDayAverage - 1156.156\ntwoHundredDayAverage - 1243.737\ntrailingAnnualDividendRate - 0.0\ntrailingAnnualDividendYield - 0.0\ncurrency - INR\nenterpriseValue - 50002583552\nforwardPE - 21.665527\nprofitMargins - 0.01898\nfloatShares - 11241411\nsharesOutstanding - 43508907\nheldPercentInsiders - 0.62915003\nheldPercentInstitutions - 0.20401\nbookValue - 396.702\npriceToBook - 2.7937849\nearningsQuarterlyGrowth - 0.384\nnetIncomeToCommon - 1025390016\ntrailingEps - 23.48\nenterpriseToRevenue - 0.926\nenterpriseToEbitda - 25.667\nquoteType - EQUITY\ncurrentPrice - 1108.3\ntargetHighPrice - 1590.0\ntargetLowPrice - 1350.0\ntargetMeanPrice - 1497.0\ntargetMedianPrice - 1524.0\nrecommendationMean - 1.5\nrecommendationKey - strong_buy\nnumberOfAnalystOpinions - 4\ntotalCash - 3179760128\ntotalCashPerShare - 73.091\nebitda - 1948120064\ntotalDebt - 3852290048\ntotalRevenue - 54025629696\ndebtToEquity - 21.76\nrevenuePerShare - 1241.809\ngrossProfits - 5259089920\nearningsGrowth - 0.381\nrevenueGrowth - 0.28\ngrossMargins - 0.09734\nebitdaMargins - 0.036059998\noperatingMargins - 0.02935\nregularMarketPrice - 1108.3\nlongName - Entero Healthcare Solutions Limited\nshortName - ENTERO HEALTHCARE SOLU L\nepsTrailingTwelveMonths - 23.48\nepsCurrentYear - 37.545\nexchange - NSI\ntrailingPegRatio - None\n--------------------------------------------------------------------------------\n[BUSINESS SUMMARY]\nEntero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.\n--------------------------------------------------------------------------------\n[IMPORTANT METRICS]\nCompany: Entero Healthcare Solutions Limited\nSector: Healthcare\nIndustry: Medical Distribution\nCountry: India\nMarket Cap: 48.22B\nCurrent Price: 1108.3\nP/E Ratio: 47.201878\nP/B Ratio: 2.7937849\nProfit Margin: 0.0190\nVolume: 71,130\nAvg Volume: 103,787\nDay Range: 1098.0 - 1128.5\n52Wk Range: 1044.9 - 1584.25\nTotal Revenue: 54025629696\nTotal Cash: 3.18B\nTotal Debt: 3.85B\nDebt to Equity: 21.76\nTarget Price: 1350.0 - 1590.0\nAnalyst Opinions: 4\nRecommendation: strong_buy\n--------------------------------------------------------------------------------\n[TECHNICAL] Close_3d:1105.50,1123.30,1108.30 | RSI:46.46 | MACD:-11.330/-15.706/4.375 | BB:1139.91/1104.10/1068.30 | MA:1104.10/1154.11 | ATR:34.15 | OBV:-1,632,539 | WillR:-39.10 | CMF:0.1207 | Ichi:1110.25/1112.40/1111.33/1176.35 | PSAR:1089.02 | Aroon:12.00/56.00 | VWAP:1201.54 | Force:149810.87 | Mass:23.82 | Coppock:0.97 | UltOsc:51.66\n--------------------------------------------------------------------------------\n[QUANT] AvgVol:79,586 | Price:1108.30 | VaR:-0.0336/-0.0616 | CVaR:-0.0487/-0.0763 | Std:0.0242 | AnnVol:0.3847 | DownDev:0.0228 | Skew:0.7749 | Kurt:5.3823 | Sharpe:-0.4654 | MaxDD:-0.3103 | VolRat:2.5646 | P/MA20:1.0038 | P/MA50:0.9603 | VolReg:0.8620 | Mom:-0.0130/-0.0751 | MeanRet:-0.0007 | W/L:0.91 | Amihud:0.000000 | Roll:0.000000 | VolSurp:-0.4780 | Omega:0.9305 | Sortino:-0.4523 | TailR:1.1116 | ESRat:1.4492 | Hurst:0.1997 | HalfL:20.24 | Mom120:-0.1417 | ApEn:0.7731",
"industry": "Medical Distribution",
"sector": "Healthcare",
"similarity_score": 0.347146064,
"symbol": "ENTERO.NS"
}
},
"llm_analysis": {
"actionable_summary": {
"action": "watch",
"bias": "neutral",
"headline": "Capillary IPO subscription closes today",
"rationale": "Await subscription and GMP data before listing"
},
"between_lines": "Media pushing retail to apply without hard numbers",
"confidence_score": 60,
"connections": {
"affects_directly": [
"Capillary Technologies"
],
"affects_indirectly": [
"SaaS sector",
"tech IPO pipeline"
],
"cause_effect_chain": "subscription demand \u2192 GMP \u2192 listing premium",
"follow_the_money": "retail oversubscription \u2192 listing pop"
},
"core": {
"action": "ipo",
"momentum": "building",
"momentum_reasoning": "Day 3 of subscription, retail and HNI interest typically peaks",
"sector": "Technology",
"topic": "IPO subscription",
"trigger": "Capillary Technologies IPO open for subscription"
},
"cross_stock_impact": [],
"data_quality": {
"article_length_tokens": 120,
"has_financial_data": false,
"has_price_data": true,
"has_sentiment_indicators": false,
"missing_critical_info": [
"subscription_status",
"GMP",
"company_financials",
"issue_size_INR"
],
"overall_quality_score": 0.4
},
"deals": {
"counterparty": [
"public"
],
"deal_currency": "lakh_shares",
"deal_size": 152.3,
"deal_type": "ipo"
},
"entities": [
{
"name": "Capillary Technologies",
"role": "issuer",
"ticker": null,
"type": "company"
}
],
"financials": {
"buyback": null,
"data_source": "inference",
"dividend": null,
"funding_amount": 877.71,
"guidance": null,
"profit": null,
"revenue": null,
"valuation": null
},
"market_reaction": {
"expected_impact": "Inference: Strong subscription \u2192 positive sentiment for SaaS IPOs",
"index_impact": [],
"price_change": null,
"volume_change": null
},
"numerical_extractions": {
"fiscal_period": null,
"mentioned_prices": [
"549",
"577"
],
"mentioned_targets": [],
"poll_source": null,
"profit_change_pct": null,
"revenue_change_pct": null,
"volume_growth_yoy_pct": null
},
"patterns": {
"pattern_reasoning": "Mid-subscription phase, GMP and subscription numbers drive sentiment",
"pattern_type": "ipo",
"similar_past_event": null,
"stage": "middle",
"strength": "moderate"
},
"rag_alignment": {
"rag_company_relevant": "no",
"relevance_reasoning": "RAG similarity only 34.71% (Entero Healthcare vs Capillary Technologies IPO) \u2013 different companies, sectors, and events",
"should_prioritize_rag": false,
"similarity_interpretation": "weak_connection"
},
"reasoning_chain": [
"IPO open 14-18 Nov",
"60 lakh fresh + 92.3 lakh OFS",
"Price band 549-577",
"Listing 21 Nov",
"No subscription/GMP data"
],
"red_flags": [
"No GMP or subscription data disclosed",
"Issue size not in \u20b9 crore",
"No financials in article"
],
"sentiment": {
"confidence": 0.7,
"direction": "neutral",
"drivers": [
"price band set",
"subscription ongoing",
"listing date fixed"
],
"intensity": 0.5
},
"signals": {
"crowd_behavior": {
"source": "inference",
"value": "FOMO"
},
"key_levels": {
"source": "article",
"values": [
"549",
"577"
]
},
"price_action_expected": {
"source": "inference",
"value": "volatile"
},
"reaction_reasoning": "Last subscription day, retail rush for allotment",
"volume_expectation": {
"source": "inference",
"value": "surge"
}
},
"smart_money": {
"big_players": [
"anchor investors",
"institutional bidders"
],
"evidence": "retail tracks GMP and subscription multiples",
"retail_position": "following",
"their_likely_motive": "allocate at floor price"
},
"timing": {
"catalyst_date": "2025-11-18",
"expected_duration_days": 3,
"temporal_anchor": "2025-11-18",
"urgency": "today"
},
"trading_angles": [
{
"conviction": "medium",
"idea": "Monitor GMP for listing pop signal",
"reasoning": "GMP \u003e \u20b980 indicates strong listing demand",
"risk": "subscription undershoot \u2192 listing discount"
},
{
"conviction": "high",
"idea": "Avoid grey-market buy; wait for listing",
"reasoning": "Retail quota limited",
"risk": "oversubscription \u2192 no allotment"
}
]
},
"metrics": {
"model_params": {
"max_completion_tokens": 8192,
"model": "moonshotai/kimi-k2-instruct-0905",
"reasoning_effort": "medium",
"stream": false,
"temperature": 0.4,
"top_p": 0.9
},
"timing": {
"end_time": "2025-11-18T21:33:51.799288",
"llm_response_seconds": 3.388,
"rag_query_seconds": 1.084,
"start_time": "2025-11-18T21:33:47.326549",
"total_duration_seconds": 4.473
},
"tokens": {
"actual_from_api": {
"input_tokens": 4680,
"output_tokens": 1020,
"total_tokens": 5700
}
}
},
"rag_match": {
"company": "Entero Healthcare Solutions Limited",
"sector": "Healthcare",
"similarity_score": 0.347146064,
"symbol": "ENTERO.NS"
},
"timestamp": "2025-11-18T21:33:51.799353"
},
"article_id": "1dcc8da9-30bb-4f69-bc8f-463ecb95c759",
"result_id": "20251118_213351",
"status": "completed"
}
Key Insights